Form DRS - Draft Registration Statement:
SEC Accession No. 0000930413-17-001614
Filing Date
2017-04-19
Accepted
2017-04-19 06:00:54
Documents
25

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1886594
2 GRAPHIC c88073xlogo1.jpg GRAPHIC 5149
3 GRAPHIC c88073xflowchart4.jpg GRAPHIC 44657
4 GRAPHIC c88073xflowchart1.jpg GRAPHIC 42905
5 GRAPHIC c88073xflowchart2.jpg GRAPHIC 33162
6 GRAPHIC c88073ximage1.jpg GRAPHIC 40664
7 GRAPHIC c88073xflowchart3.jpg GRAPHIC 41712
8 GRAPHIC c88073xbarchart1.jpg GRAPHIC 9081
9 GRAPHIC c88073xbarchart2.jpg GRAPHIC 8448
10 GRAPHIC c88073xbarchart3.jpg GRAPHIC 7159
11 GRAPHIC c88073xbarchart4.jpg GRAPHIC 9008
12 GRAPHIC c88073xbarchart5.jpg GRAPHIC 11644
13 GRAPHIC c88073xbarchart6.jpg GRAPHIC 11493
14 GRAPHIC c88073ximage2.jpg GRAPHIC 26755
15 GRAPHIC c88073xrider93.jpg GRAPHIC 7864
16 GRAPHIC c88073xfig10.jpg GRAPHIC 16060
17 GRAPHIC c88073xlinechart2.jpg GRAPHIC 14136
18 GRAPHIC c88073xlogo2.jpg GRAPHIC 6011
19 filename19.htm EX-3.3 24643
20 filename20.htm EX-4.2 224769
21 filename21.htm EX-10.1 257579
22 filename22.htm EX-10.2 119771
23 filename23.htm EX-10.3 108785
24 filename24.htm EX-10.4 360164
25 filename25.htm EX-10.5 148355
  Complete submission text file 0000930413-17-001614.txt   3596756
Mailing Address 1375 TRANS-CANADA HIGHWAY SUITE 200 DORVAL A8 H9P 2W8
Business Address 1375 TRANS-CANADA HIGHWAY SUITE 200 DORVAL A8 H9P 2W8 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

EIN.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01547 | Film No.: 17768066
SIC: 2834 Pharmaceutical Preparations